Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: A prospective cohort analysis among african couples

PLoS Medicine

Volumn 9, Issue 6, 2012, Pages 18-

  Cohen, Craig R ^a,b   Lingappa, Jairam R ^c,d   Baeten, Jared M ^c   Ngayo, Musa O ^e   Spiegel, Carol A ^f   Hong, Ting ^c   Donnell, Deborah ^g   Celum, Connie ^c   Kapiga, Saidi ^h   Delany, Sinead ⁱ   Bukusi, Elizabeth A ^a,c,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; AFRICA; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; RISK FACTOR; SEQUENCE ANALYSIS; VAGINITIS; VIRUS TRANSMISSION; WESTERN BLOTTING; BLOOD; CLINICAL TRIAL (TOPIC); DISEASE TRANSMISSION; FAMILY SIZE; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; VAGINA; VIROLOGY;

ADULT; AFRICA; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; FAMILY CHARACTERISTICS; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; VAGINA; VAGINOSIS, BACTERIAL;

EID: 84864703034     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001251     Document Type: Article

References (51)

1. (UNAIDS) JUNPoHA (2010) Global report: UNAIDS report on the global AIDS epidemic 2010 New York UNAIDS.
2. Chaisson RE, Keruly JC, Moore RD, (2000) Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy. JAMA 284: 3128 3129.
3. Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, (2007) Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS 21: 501 507.
4. Donnell D, Baeten JM, Kiarie J, Thomas KK, Stevens W, (2010) Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092 2098.
5. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, (2011) Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 365: 493 505.
6. Fredricks DN, Fiedler TL, Marrazzo JM, (2005) Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 353: 1899 1911.
7. Mitchell C, Moreira C, Fredricks D, Paul K, Caliendo AM, (2009) Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis. Infect Dis Obstet Gynecol 2009: 236919.
8. Bukusi EA, Cohen CR, Meier AS, Waiyaki PG, Nguti R, (2006) Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis 33: 361 367.
9. Martin HL, Richardson BA, Nyange PM, Lavreys L, Hillier SL, (1999) Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 180: 1863 1868.
10. Sewankambo N, Gray RH, Wawer MJ, Paxton L, McNaim D, (1997) HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 546 550.
11. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS, (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22: 1493 1501.
12. Coleman JS, Hitti J, Bukusi EA, Mwachari C, Muliro A, (2007) Infectious correlates of HIV-1 shedding in the female upper and lower genital tracts. AIDS 21: 755 759.
13. Sha BE, Zariffard MR, Wang QJ, Chen HY, Bremer J, (2005) Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis. J Infect Dis 191: 25 32.
14. Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, (2001) The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 183: 1017 1022.
15. Hashemi FB, Ghassemi M, Faro S, Aroutcheva A, Spear GT, (2000) Induction of human immunodeficiency virus type 1 expression by anaerobes associated with bacterial vaginosis. J Infect Dis 181: 1574 1580.
16. Simoes JA, Hashemi FB, Aroutcheva AA, Heimler I, Spear GT, (2001) Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics. J Infect Dis 184: 22 27.
17. Clemetson DB, Moss GB, Willerford DM, Hensel M, Emonyi W, (1993) Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. JAMA 269: 2860 2864.
18. Rebbapragada A, Howe K, Wachihi C, Pettengell C, Sunderji S, (2008) Bacterial vaginosis in HIV-infected women induces reversible alterations in the cervical immune environment. J Acquir Immune Defic Syndr 49: 520 522.
19. Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, (2010) Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362: 427 439.
20. Nugent RP, Krohn MA, Hillier SL, (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29: 297 301.
21. Forsum U, Jakobsson T, Larsson PG, Schmidt H, Beverly A, (2002) An international study of the interobserver variation between interpretations of vaginal smear criteria of bacterial vaginosis. APMIS 110: 811 818.
22. Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, (2011) Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One 6: e16986 doi:10.1371/journal.pone.0016986.
23. Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, (2009) Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial. Lancet 375: 824 833.
24. Sahai H, (1996) Statistics in epidemiology: methods, techniques, and applications. In: Sahai H, Khurshid A, editors. Boca Raton (Florida) CRC Press.
25. Baeten JM, Kahle E, Lingappa JR, Coombs RW, Delany-Moretlwe S, (2011) Genital HIV-1 RNA predicts risk of heterosexual HIV-1 transmission. Sci Transl Med 3: 77ra29.
26. Tanton C, Weiss HA, Le Goff J, Changalucha J, Rusizoka M, (2011) Correlates of HIV-1 genital shedding in Tanzanian Women. PLoS One 6: e17480 doi:10.1371/journal.pone.0017480.
27. Moreira C, Venkatesh KK, DeLong A, Liu T, Kurpewski J, (2009) Effect of treatment of asymptomatic bacterial vaginosis on HIV-1 shedding in the genital tract among women on antiretroviral therapy: a pilot study. Clin Infect Dis 49: 991 992.
28. Cohen CR, Plummer FA, Mugo N, Maclean I, Shen C, (1999) Increased interleukin-10 in the the endocervical secretions of women with non-ulcerative sexually transmitted diseases: a mechanism for enhanced HIV-1 transmission? AIDS 13: 327 332.
29. Bukusi EA, Thomas K, Nguti R, Cohen CR, Weiss N, (2011) Topical penile microbicide use by men to prevent recurrent bacterial vaginosis in sex partners: a randomized clinical trial. Sex Transm Dis 38: 483 489.
30. Gray RH, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, (2009) The effects of male circumcision on female partners' genital tract symptoms and vaginal infections in a randomized trial in Rakai, Uganda. Am J Obstet Gynecol 200: 42 e41 e47.
31. Price LB, Liu CM, Johnson KE, Aziz M, Lau MK, (2010) The effects of circumcision on the penis microbiome. PLoS One 5: e8422 doi:10.1371/journal.pone.0008422.
32. Donoval BA, Landay AL, Moses S, Agot K, Ndinya-Achola JO, (2006) HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 125: 386 391.
33. de Jong MA, Geijtenbeek TB, (2009) Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players. J Intern Med 265: 18 28.
34. Klebanoff MA, Schwebke JR, Zhang J, Nansel TR, Yu KF, (2004) Vulvovaginal symptoms in women with bacterial vaginosis. Obstet Gynecol 104: 267 272.
35. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, (1983) Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 74: 14 22.
36. Baeten JM, Strick LB, Lucchetti A, Whittington WL, Sanchez J, (2008) Herpes simplex virus (HSV)-suppressive therapy decreases plasma and genital HIV-1 levels in HSV-2/HIV-1 coinfected women: a randomized, placebo-controlled, cross-over trial. J Infect Dis 198: 1804 1808.
37. Eschenbach DA, (1993) History and review of bacterial vaginosis. Am J Obstet Gynecol 169: 441 445.
38. Greenblatt RM, Bacchetti P, Barkan S, Augenbraun M, Silver S, (1999) Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS). Sex Transm Dis 26: 143 151.
39. Bradshaw CS, Morton AN, Hocking J, Garland SM, Morris MB, (2006) High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 193: 1478 1486.
40. Tabrizi SN, Fairley CK, Bradshaw CS, Garland SM, (2006) Prevalence of Gardnerella vaginalis and Atopobium vaginae in virginal women. Sex Transm Dis 33: 663 665.
41. Verstraelen H, Verhelst R, VaneechoutteTemmerman MM, The epidemiology of bacterial vaginosis in relation to sexual behaviour. BMC Infect Dis 10: 81.
42. McClelland RS, Richardson BA, Hassan WM, Chohan V, Lavreys L, (2008) Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis 197: 1361 1368.
43. Anukam KC, Osazuwa E, Osemene GI, Ehigiagbe F, Bruce AW, (2006) Clinical study comparing probiotic Lactobacillus GR-1 and RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes Infect 8: 2772 2776.
44. Bolton M, van der Straten A, Cohen CR, (2008) Probiotics: potential to prevent HIV and sexually transmitted infections in women. Sex Transm Dis 35: 214 225.
45. Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, (2010) Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Sex Transm Dis 37: 745 750.
46. Swidsinski A, Mendling W, Loening-Baucke V, Ladhoff A, Swidsinski S, (2005) Adherent biofilms in bacterial vaginosis. Obstet Gynecol 106: 1013 1023.
47. Swidsinski A, Mendling W, Loening-Baucke V, Swidsinski S, Dorffel Y, (2008) An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole. Am J Obstet Gynecol 198: 97 e91 96.
48. Thoma ME, Gray RH, Kiwanuka N, Aluma S, Wang MC, (2011) The Short-term Variability of Bacterial Vaginosis Diagnosed by Nugent Gram Stain Criteria Among Sexually Active Women in Rakai, Uganda. Sex Transm Dis 38: 111 116.
49. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353: 525 535.
50. Hemmerling A, Cohen CR, (2011) Probiotics: the potential for a live microbicide to prevent HIV. J Acquir Immune Defic Syndr 56: e98 101.
51. MacPhee RA, Hummelen R, Bisanz JE, Miller WL, Reid G, (2010) Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother 11: 2985 2995.